| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/30/2003 | CN1432381A Chinese medicine for treating various rheumarthritis |
| 07/30/2003 | CN1432380A Bone setting pills for promoting fracture healing and its prepn process |
| 07/30/2003 | CN1432377A Plaster for treating rheumatic diseases and psoatic strain and its prepn process |
| 07/30/2003 | CN1116070C Medical wine for treating rheuamtism, fracture and injury and preparing process thereof |
| 07/30/2003 | CN1116065C Plaster for treating ostalgia and its preparing process |
| 07/30/2003 | CN1116064C Medicine for treating hyperosteogeny |
| 07/30/2003 | CN1116061C Traditional Chinese medicine fused magnetized xenogenous protein for treating prolapse of lumbar intervertebrai disc and cervical spondylopathy and preparation process thereof |
| 07/30/2003 | CN1116055C Medicine for treating fracture |
| 07/29/2003 | US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 07/29/2003 | US6600052 With a ring cyclizing reagent to form the compound of Formula V to yield a compound of Formula V: inhibitors of the cyclooxygenase- II enzyme. and antiinflammatory agents and analgesic pharmaceutical agents. |
| 07/29/2003 | US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis |
| 07/29/2003 | US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity |
| 07/29/2003 | US6599932 Highly selective in killing tumor cells but not normal cells |
| 07/29/2003 | US6599925 Cardiovascular disorders; anticancer agents |
| 07/29/2003 | US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| 07/29/2003 | US6599910 Substituted triazole compounds |
| 07/29/2003 | US6599890 Inhibitors of matrix metalloproteinases or the production of tumor necrosis factor |
| 07/29/2003 | US6599888 These combinations have shown a synergistic effect compared with compositions containing either glucosamine alone, or chondroitin sulfate alone |
| 07/29/2003 | US6599875 IL-6 antagonist peptides |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599506 Inhibiting integrin-associated diseases; rejection of transplanted organs, allergies, and autoimmune diseases |
| 07/29/2003 | US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/29/2003 | CA2188030C Use of bisphophonates for inhibiting bone resorption following implantation of orthopedic prosthesis |
| 07/24/2003 | WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060126A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003060071A2 Albumin fusion proteins |
| 07/24/2003 | WO2003059950A1 Ifnar2 mutants, their production and use |
| 07/24/2003 | WO2003059932A2 Methods of inducing or enhancing connective tissue repair |
| 07/24/2003 | WO2003059921A1 Mmp inhibitors |
| 07/24/2003 | WO2003059913A1 Roh-kinase inhibitors |
| 07/24/2003 | WO2003059905A1 Pyrrolidone carboxamides |
| 07/24/2003 | WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059872A1 Avb3 and avb5 integrin antagonists and methods of treating diseases or conditions associated with avb3 and avb5 integrins |
| 07/24/2003 | WO2003059370A1 Crude drug compositions for treating or preventing arthritic diseases and the preparation process |
| 07/24/2003 | WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 07/24/2003 | WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | WO2003059293A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/24/2003 | WO2003059291A2 Treatment of bone disorders with skeletal anabolic drugs |
| 07/24/2003 | WO2003059283A2 Compounds for blocking androgen receptors |
| 07/24/2003 | WO2003059269A2 Acridone inhibitors of impdh enzyme |
| 07/24/2003 | WO2003059252A2 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | WO2003045333A3 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 07/24/2003 | WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | WO2003028713A3 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 07/24/2003 | WO2003011895A3 Compositions and methods for modulation of immune responses |
| 07/24/2003 | WO2003011221A3 PREPARATION AND USE OF α-KETO PHOSPHONATES |
| 07/24/2003 | WO2003009741A3 Methods for treating joint inflammation, pain, and loss of mobility |
| 07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
| 07/24/2003 | US20030139811 Orthopedic hardware with a sustained release device configured to release a compound over an extended period of time and is attachable to a portion of the body |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139574 Active hedgehog protein conjugate |
| 07/24/2003 | US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139452 Pyrazole-derived kinase inhibitors and uses thereof |
| 07/24/2003 | US20030139446 Reacting with acid mixed with solvent; salt formation |
| 07/24/2003 | US20030139439 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/24/2003 | US20030139435 N-heterocyclic inhibitors of TNF-alpha expression |
| 07/24/2003 | US20030139434 Combinations comprising dipeptidylpeptidase-iv inhibitor |
| 07/24/2003 | US20030139421 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 07/24/2003 | US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 07/24/2003 | US20030139414 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 07/24/2003 | US20030139413 Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them |
| 07/24/2003 | US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles |
| 07/24/2003 | US20030139400 Controlling cell differentiation; antiinflammatory agents |
| 07/24/2003 | US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 07/24/2003 | US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/24/2003 | US20030139394 Dibenzodiazepine derivatives, their preparation and use |
| 07/24/2003 | US20030139391 Efficacious dosage regimen of galantamine that reduces side effects |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/24/2003 | US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders |
| 07/24/2003 | US20030139378 Liquid bisphosphonate formulations for bone disorders |
| 07/24/2003 | US20030139376 Lipoxin A4 analogs |
| 07/24/2003 | US20030139372 Modulation of bone formation |
| 07/24/2003 | US20030139354 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases |
| 07/24/2003 | US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders |
| 07/24/2003 | US20030139350 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 07/24/2003 | US20030139326 Antiinflammatory agents; autoimmune disease |
| 07/24/2003 | US20030139325 Complex comprising OCIF and polysaccharide |
| 07/24/2003 | US20030138926 Novel polynucleotides and polypeptides encoded thereby |
| 07/24/2003 | US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy |
| 07/24/2003 | US20030138423 Antiinflammation agents and immunotherapy using an enzyme inhibitor; sepsis; antiarthritic and - ulcer agents; colitis; myocarditis; glomerulonephritis; gastrointestinal and nervous system disorders; Crohn's disease; automimmune |
| 07/24/2003 | US20030138422 Antibodies against growth and differentiation factor-8 (GDF-8), also known as myostatin, including fragments; muscle and bone degenerative disorders; muscular dystropy/atrophy; antidiabetic agents; congestive obstructive pulmonary disease |
| 07/24/2003 | US20030138421 Human Antibodies specific for interleukin 15 (IL-15) |
| 07/24/2003 | US20030138407 Therapeutic methods for nucleic acid delivery vehicles |
| 07/24/2003 | CA2841097A1 Albumin fusion proteins |
| 07/24/2003 | CA2474239A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | CA2473908A1 Compounds for blocking androgen receptors |
| 07/24/2003 | CA2473893A1 Stable salts of o-acetylsalicylic acid with basic amino acids ii |
| 07/24/2003 | CA2472746A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | CA2472619A1 Fused pyrimidine derivates as rho-kinase inhibitors |
| 07/24/2003 | CA2472472A1 Treatment of bone disorders with skeletal anabolic drugs |
| 07/24/2003 | CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | CA2472168A1 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |